Experimental ALS drug

Dr. Devi Nampiaparampil comments on the news that a panel of FDA health advisers voted to recommend approval for an experimental drug from Amylyx Pharma to treat amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.